New study shows promising link between cutting back on drinking and Ozempic

ABC News contributor Dr. Alok Patel talks about a new study on the relationship between Ozempic and alcohol-use disorders.
4:00 | 12/04/23

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for New study shows promising link between cutting back on drinking and Ozempic
LISTEN TO EVERY EPISODE WHEREVER YOU GET YOUR PODCASTS WHEREVER YOU GET YOUR PODCASTS . . >> SO THERE IS THIS >> SO THERE IS THIS NEW PRELIMINARY RESEARCH NEW PRELIMINARY RESEARCH ABOUT OZEMPIC AND IT'S RAISING ABOUT OZEMPIC AND IT'S RAISING HOPE FOR PEOPLE WHO STRUGGLE HOPE FOR PEOPLE WHO STRUGGLE WITH DRINKING ALCOHOL. WITH DRINKING ALCOHOL. IT FINDS THAT THE WEIGHT IT FINDS THAT THE WEIGHT DRUG MAY ALSO HELP PREVENT DRUG MAY ALSO HELP PREVENT ALCOHOL. ALCOHOL. ALCOHOL ABUSE. ALCOHOL ABUSE. RESEARCHERS ARE EXPLORING RESEARCHERS ARE EXPLORING WHETHER IT HAS THE POTENTIAL WHETHER IT HAS THE POTENTIAL TO OTHER ADDICTIVE BEHAVIORS TO OTHER ADDICTIVE BEHAVIORS AS WELL. AS WELL. HERE'S OUR ERIELLE RESHEF. HERE'S OUR ERIELLE RESHEF. WOW. WOW. I HAVE NO DESIRE TO DRINK WINE I HAVE NO DESIRE TO DRINK WINE ANYMORE. ANYMORE. AND IT'S IT'S THAT'S CRAZY AND IT'S IT'S THAT'S CRAZY TO ME BECAUSE I COULDN'T STOP TO ME BECAUSE I COULDN'T STOP BEFORE THE WILDLY POPULAR BEFORE THE WILDLY POPULAR DRUG USED FOR WEIGHT LOSS, DRUG USED FOR WEIGHT LOSS, SEMAGLUTIDE IS NOW SHOWING VERY SEMAGLUTIDE IS NOW SHOWING VERY EARLY SIGNS OF POTENTIAL EARLY SIGNS OF POTENTIAL CURBING ALCOHOL USE FOR THOSE CURBING ALCOHOL USE FOR THOSE WHO DRINK EXCESSIVELY. WHO DRINK EXCESSIVELY. A NEW CASE STUDY COMPOSED A NEW CASE STUDY COMPOSED OF SIX PEOPLE SCREENING OF SIX PEOPLE SCREENING POSITIVE FOR ALCOHOL POSITIVE FOR ALCOHOL USE DISORDER OR UDY, FOUND USE DISORDER OR UDY, FOUND THAT THEY ALL SAW A CLINICALLY THAT THEY ALL SAW A CLINICALLY SIGNIFICANT DECREASE SIGNIFICANT DECREASE IN SYMPTOMS WHILE. IN SYMPTOMS WHILE. >> THEY WERE USING SEMAGLUTIDE >> THEY WERE USING SEMAGLUTIDE FOR WEIGHT LOSS. FOR WEIGHT LOSS. CHRISTY MARTIN, WHO NOT PART CHRISTY MARTIN, WHO NOT PART OF THE STUDY, SAYS WHILE SHE OF THE STUDY, SAYS WHILE SHE USED TO DRINK WINE EVERY NIGHT USED TO DRINK WINE EVERY NIGHT HER URGE TO DRINK HAS HER URGE TO DRINK HAS DISAPPEARED. DISAPPEARED. >> DRINKING FOR WAS BECOMING >> DRINKING FOR WAS BECOMING A BIT OF AN ISSUE AND THE FACT A BIT OF AN ISSUE AND THE FACT I JUST HAVE NO DESIRE FOR IT I JUST HAVE NO DESIRE FOR IT IS SOMETHING I DIDN'T EXPECT IS SOMETHING I DIDN'T EXPECT IS JUST AN AMAZING SIDE IS JUST AN AMAZING SIDE BENEFIT. BENEFIT. I CAN'T EVEN TELL YOU THIS I CAN'T EVEN TELL YOU THIS SMALL CASE STUDY NOW SETTING SMALL CASE STUDY NOW SETTING THE STAGE FOR LARGER CLINICAL THE STAGE FOR LARGER CLINICAL TRIALS, LOOKING AT SEMAGLUTIDE TRIALS, LOOKING AT SEMAGLUTIDE AS A TREATMENT FOR IUD. AS A TREATMENT FOR IUD. AS RESEARCHERS EXPLORE WHETHER AS RESEARCHERS EXPLORE WHETHER THE DRUG HAS THE POTENTIAL, THE DRUG HAS THE POTENTIAL, TREAT OTHER EXCESSIVE TREAT OTHER EXCESSIVE USE CONDITIONS, AGAIN, THIS USE CONDITIONS, AGAIN, THIS INITIAL STUDY ONLY INCLUDED INITIAL STUDY ONLY INCLUDED SIX PATIENTS, BUT AS YOU HEARD SIX PATIENTS, BUT AS YOU HEARD MORE THOROUGH, STUDIES MORE THOROUGH, STUDIES ARE ALREADY UNDERWAY. ARE ALREADY UNDERWAY. IT COULD BE YEARS BEFORE KNOW IT COULD BE YEARS BEFORE KNOW THE TRUE RESULTS, BUT CERTAINLY THE TRUE RESULTS, BUT CERTAINLY REASON TO HOPE KYRA. REASON TO HOPE KYRA. >> OH, YEAH. >> OH, YEAH. ERIELLE, THANK YOU SO MUCH. ERIELLE, THANK YOU SO MUCH. BOY, WOULD THAT IMPACT A LOT BOY, WOULD THAT IMPACT A LOT OF PEOPLE. OF PEOPLE. A LOT WONDERFUL WAY COULD HELP A LOT WONDERFUL WAY COULD HELP WITH WHAT FOR MANY IS AN WITH WHAT FOR MANY IS AN INSOLUBLE. INSOLUBLE. SO LET'S BRING IN ABC NEWS SO LET'S BRING IN ABC NEWS MEDICAL CONTRIBUTOR MEDICAL CONTRIBUTOR AND PHYSICIAN AT STANFORD AND PHYSICIAN AT STANFORD CHILDREN'S HEALTH CHILDREN'S HEALTH DR. ALOK PATEL. DR. ALOK PATEL. SO, DR. PATEL, IT'S GREAT SO, DR. PATEL, IT'S GREAT TO SEE YOU. TO SEE YOU. WHAT DO YOU MAKE OF THIS WHAT DO YOU MAKE OF THIS PRELIMINARY RESEARCH PRELIMINARY RESEARCH ABOUT OZEMPIC AND SIMILAR? ABOUT OZEMPIC AND SIMILAR? DO YOU THINK THAT THEY COULD DO YOU THINK THAT THEY COULD PLAY A ROLE IN WHAT IS, PLAY A ROLE IN WHAT IS, YOU KNOW, DEMAND PROBLEM YOU KNOW, DEMAND PROBLEM IN THIS COUNTRY AFFECTS SO MANY IN THIS COUNTRY AFFECTS SO MANY FAMILIES? FAMILIES? ALCOHOL ABUSE. ALCOHOL ABUSE. >> ERIC, HERE IS ALWAYS >> ERIC, HERE IS ALWAYS A PLEASURE TO TALK WITH BOTH A PLEASURE TO TALK WITH BOTH OF YOU. OF YOU. YOU KNOW, THIS PRELIMINARY YOU KNOW, THIS PRELIMINARY STUDY ADDS TO A BODY STUDY ADDS TO A BODY OF ANECDOTAL EVIDENCE OF ANECDOTAL EVIDENCE AND CLINICAL REPORTS FROM AND CLINICAL REPORTS FROM PATIENTS WHO HAVE BEEN USING PATIENTS WHO HAVE BEEN USING THESE JLC ONE AGONISTS. THESE JLC ONE AGONISTS. THIS CLASS MEDICATIONS FOR THIS CLASS MEDICATIONS FOR YEARS, AND SAY THAT SOME YEARS, AND SAY THAT SOME OF THEIR PATIENTS ARE REPORTING OF THEIR PATIENTS ARE REPORTING NOT WANTING TO DRINK AS MUCH NOT WANTING TO DRINK AS MUCH ANYMORE. ANYMORE. EVEN SOME PATIENTS REPORTING EVEN SOME PATIENTS REPORTING A REDUCTION IN. A REDUCTION IN. OTHER ADDICTIVE BEHAVIORS OTHER ADDICTIVE BEHAVIORS AS WELL, LIKE SMOKING, NICOTINE AS WELL, LIKE SMOKING, NICOTINE USE, EVEN SHOPPING USE, EVEN SHOPPING AND GAMBLING. AND GAMBLING. >> AND SO THIS IS AN IMPORTANT >> AND SO THIS IS AN IMPORTANT STEP FORWARD. STEP FORWARD. WE UNDERSTAND MORE ABOUT WE UNDERSTAND MORE ABOUT HOW EXACTLY SEMAGLUTIDE CAN HOW EXACTLY SEMAGLUTIDE CAN CURB NOT JUST APPETITE CURB NOT JUST APPETITE AND REDUCE WEIGHT AND CONTROL AND REDUCE WEIGHT AND CONTROL BLOOD SUGAR, BUT THESE OTHER BLOOD SUGAR, BUT THESE OTHER BEHAVIORS AS WELL, LIKE ALCOHOL BEHAVIORS AS WELL, LIKE ALCOHOL CONSUMPTION. CONSUMPTION. SO REALLY IMPORTANT STEP SO REALLY IMPORTANT STEP FORWARD AS WE'RE LOOKING FORWARD AS WE'RE LOOKING AT MORE RESEARCH. AT MORE RESEARCH. >> OKAY. >> OKAY. I'M TRYING TO FIGURE OUT THE I I'M TRYING TO FIGURE OUT THE I COULD UNDERSTAND SMOKING COULD UNDERSTAND SMOKING ALCOHOL, BUT SHOPPING. ALCOHOL, BUT SHOPPING. SO IT'S NOT JUST SOMETHING SO IT'S NOT JUST SOMETHING I MEAN, EXPLAIN THE MENTAL I MEAN, EXPLAIN THE MENTAL TRIGGERS HERE. TRIGGERS HERE. NOW, KYRA, YOUR NEUROLOGICAL NOW, KYRA, YOUR NEUROLOGICAL WHEELS ARE SPINNING JUST LIKE WHEELS ARE SPINNING JUST LIKE MINE AND A LOT OF RESEARCHERS. MINE AND A LOT OF RESEARCHERS. NOW, ONE OF THE THEORIES NOW, ONE OF THE THEORIES WITH CONSUMPTION, WHETHER WITH CONSUMPTION, WHETHER THAT IS ALCOHOL OR ANOTHER THAT IS ALCOHOL OR ANOTHER SUBSTANCES, YOU MEAN IT'S NOT SUBSTANCES, YOU MEAN IT'S NOT ONE THAT YOUR STOMACH MAY KIND ONE THAT YOUR STOMACH MAY KIND OF SAY, HEY, YOU KNOW WHAT, OF SAY, HEY, YOU KNOW WHAT, WE'RE GOOD DON'T DRINK ANYMORE. WE'RE GOOD DON'T DRINK ANYMORE. BUT SOME SCIENTISTS ARE LOOKING BUT SOME SCIENTISTS ARE LOOKING AT THE FACT THAT THESE AT THE FACT THAT THESE MEDICATIONS MAY ACTUALLY ACT MEDICATIONS MAY ACTUALLY ACT IN THE AREA OF THE BRAIN THAT'S IN THE AREA OF THE BRAIN THAT'S RESPONSIBLE FOR THE REWARD. RESPONSIBLE FOR THE REWARD. SO IF YOU HAVE AN EXTRA DONUT, SO IF YOU HAVE AN EXTRA DONUT, BEER OR, YOU GO ONLINE BEER OR, YOU GO ONLINE TO SHOCK. TO SHOCK. >> YOUR BODY, RELEASES >> YOUR BODY, RELEASES DOPAMINE. DOPAMINE. SO IT'S POSSIBLE WE MAY LEARN SO IT'S POSSIBLE WE MAY LEARN IN THE FUTURE THAT THIS IN THE FUTURE THAT THIS IS ANOTHER AREA WHERE SIMILAR IS ANOTHER AREA WHERE SIMILAR TYPES POTENTIALLY OFFER TYPES POTENTIALLY OFFER SOME TREATMENT AND STUFF. SOME TREATMENT AND STUFF. BUT AGAIN, WE NEED BUT AGAIN, WE NEED MORE RESEARCH. MORE RESEARCH. >> BUT THIS IS KIND OF AN >> BUT THIS IS KIND OF AN EXCITING NEW VENTURE IN THIS EXCITING NEW VENTURE IN THIS SPACE, IS FASCINATING SPACE, IS FASCINATING AND REALLY DOES OFFER A LOT AND REALLY DOES OFFER A LOT OF PROMISE TO THIS, YOU KNOW,

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"4:00","description":"ABC News contributor Dr. Alok Patel talks about a new study on the relationship between Ozempic and alcohol-use disorders.","mediaType":"default","section":"ABCNews/Health","id":"105367534","title":"New study shows promising link between cutting back on drinking and Ozempic","url":"/Health/video/new-study-shows-promising-link-cutting-back-drinking-105367534"}